Home › Funds › BAKER BROS. ADVISORS LP › SMMT
BAKER BROS. ADVISORS LP position in SMMT
SUMMIT THERAPEUTICS INC · Health Care
BAKER BROS. ADVISORS LP reported holding 32,786,348 shares of SMMT (SUMMIT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$477.7M, representing 2.50% of its reported portfolio and ranking #12 among its reported holdings. BAKER BROS. ADVISORS LP has disclosed SMMT holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BAKER BROS. ADVISORS LP's SMMT position evolved
BAKER BROS. ADVISORS LP first disclosed a stake in SMMT in Q3 2023 at 3,140,473 shares (US$5.9M). The position peaked in Q2 2025 at 33,722,974 shares, worth US$717.6M. Across 10 filings, BAKER BROS. ADVISORS LP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 32,786,348 shares valued at US$477.7M — a reduction of -3,604,715 shares quarter over quarter.. Notable position changes include a 38% increase in Q2 2025 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.14M | $5.87M | New |
| Q2 2024 | 23.22M | $181.13M | New |
| Q3 2024 | 24.42M | $534.90M | Add |
| Q4 2024 | 24.42M | $435.86M | Hold |
| Q1 2025 | 24.42M | $471.16M | Hold |
| Q2 2025 | 33.72M | $717.62M | Add |
| Q3 2025 | 33.72M | $696.72M | Hold |
| Q4 2025 | 36.39M | $636.48M | Add |
| Q1 2026 | 36.39M | $689.97M | Hold |
| Q2 2026 | 32.79M | $477.70M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SMMT and 13F data
SMMT (SUMMIT THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in SMMT — the largest reported positions include Logos Global Management LP (US$19.7M), Octagon Capital Advisors LP (US$18.2M), Kynam Capital Management, LP (US$17.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SMMT
- Logos Global Management LP 1.35M sh · $19.67M · Q2 2026
- Octagon Capital Advisors LP 1.25M sh · $18.21M · Q2 2026
- Kynam Capital Management, LP 1.20M sh · $17.48M · Q2 2026
- APEIRON CAPITAL Ltd 961.87K sh · $14.01M · Q2 2026
- Elmind Capital, LP 493.82K sh · $7.19M · Q2 2026
More on BAKER BROS. ADVISORS LP
FAQ
How long has BAKER BROS. ADVISORS LP held SMMT?
BAKER BROS. ADVISORS LP has disclosed SMMT holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
What is BAKER BROS. ADVISORS LP's current position in SMMT?
As of Q2 2026, BAKER BROS. ADVISORS LP holds 32.79M shares of SMMT (SUMMIT THERAPEUTICS INC), valued at $477.70M, representing 2.50% of its reported portfolio and ranking #12.
Has BAKER BROS. ADVISORS LP been buying or selling SMMT?
In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP reduced its position in SMMT. The position peaked in Q2 2025 at 33.72M shares.
Which other funds hold SMMT?
Other major institutional holders of SMMT include Logos Global Management LP, Octagon Capital Advisors LP, Kynam Capital Management, LP, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.